Real-world study of Surufatinib combined with hepatic artery infusion chemotherapy (HAIC) for high-grade neuroendocrine neoplasm

被引:0
|
作者
Wang, Y. [1 ]
Yu, H. [1 ]
Yang, D. [1 ]
Liu, H. [1 ]
Yao, W. [1 ]
Chen, L. [1 ]
Liu, M. [1 ]
Zhang, N. [1 ]
机构
[1] Zhongshan Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
关键词
real-world study; surufatinib; hepatic artery infusion chemotherapy; high-grade neuroendocrine neoplasm;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
I32
引用
收藏
页码:256 / 256
页数:1
相关论文
共 50 条
  • [1] Use of alkylating chemotherapy in high-grade neuroendocrine tumours: Evaluation of real-world data.
    Sathiyapalan, Arani
    Sanatani, Michael Susmoy
    Welch, Stephen
    Kocha, Walter Ilarion
    Richter, Sue
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [2] Surufatinib combined with sintilimab and IBI310 in the treatment of high-grade advanced-neuroendocrine neoplasm: A single arm, open-label, multicenter study
    Lu, M.
    Wang, Y.
    Zhang, P.
    Shen, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S770 - S770
  • [3] A real-world, population-based study of the trends for incidence and prognosis in high-grade neuroendocrine tumor of cervix
    Yang, Xi-Lin
    Guan, Wen-Ju
    Kou, Ling-Na
    Wang, Ming-Ming
    Lai, Hua
    Wu, Da-Jun
    CURRENT PROBLEMS IN CANCER, 2022, 46 (02)
  • [4] Performance of surufatinib in treating advanced neuroendocrine neoplasms: Insights from a real-world study
    Zhu, Linhui
    Ye, Xuan
    She, Youjun
    Liu, Wensheng
    Du, Qiong
    Zhai, Qing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors for advanced hepatocellular carcinoma
    Liu, Bao-Jiang
    Gao, Song
    Zhu, Xu
    Guo, Jian-Hai
    Kou, Fu-Xin
    Liu, Shao-Xing
    Zhang, Xin
    Wang, Xiao-Dong
    Cao, Guang
    Chen, Hui
    Liu, Peng
    Xu, Hai-Feng
    Gao, Qin-Zong
    Yang, Ren-Jie
    IMMUNOTHERAPY, 2021, 13 (17) : 1395 - 1405
  • [6] Primary results of DAYDREAM study, a real-world multicentre study on the efficacy of adjuvant chemotherapy in high-grade uterine sarcomas
    Martinez, Alejandro Gallego
    Martin-Calvo, Nerea
    Meydanli, Mehmet Mutlu
    Khatib, Ghanim
    Kaidarova, Dilyara
    Ayhan, Ali
    Borella, Fulvio
    Sanchez-Salcedo, Marco
    Sanci, Muzaffer
    Chaves, Claudia Bessa Bessa Pereira
    Elsersy, Mervat Ali Mohamed
    Bolatbekova, Raikhan
    Vorias, George
    Gil-Moreno, Antonio
    Perrone, Anna Myriam
    Mishra, Jagannath
    Zusterzeel, Petra
    Theodoulidis, Vasilis
    Aluloski, Igor
    De Kroon, Cornelis D.
    Comerci, Giuseppe
    Toptas, Tayfun
    Fruscio, Robert
    Sanchez, Octavio Arencibia
    Caba, Maria De Marino
    Niine-Roolah, Eva-Maria
    Martin-Salamanca, Belen
    Lopez, Elena Cabezas
    Scollo, Paolo
    Blecharz, Pawel
    Siegenthaler, Franziska
    Bacila, Mihai
    Gennigens, Christine
    Gonzalez-Martin, Antonio
    De Agustin, Luis Chiva
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A573 - A573
  • [7] Therapeutic strategy analysis of patients with advanced stage high-grade neuroendocrine cervical cancer: A real-world multicenter study
    Zhang, Yuanyuan
    Huang, Yi
    Luo, Suiyu
    Li, Lin
    Yang, Hongying
    Wang, Ziyi
    Peng, Yongmei
    Huang, Manni
    An, Jusheng
    Yang, Xi
    Wang, Jing
    Li, Chunmei
    Wu, Lingying
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 158 (03) : 722 - 729
  • [8] Hepatic artery infusion chemotherapy combined with apatinib and toripalimab in advanced hepatocellular carcinoma: Real-world data from a single center.
    Gu, Yang-Kui
    Zhang, Tian-Qi
    Huang, Zi-Lin
    Geng, Zhi-Jun
    Chen, Chen
    Li, Fu-Gui
    Xu, Li
    Sun, Jian
    Li, Jibin
    Huang, Zhi-Mei
    Shen, Lujun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese population
    Liu, Yuanyuan
    Yang, Xinyi
    Wang, Yan
    Xie, Songzuo
    Li, Minxing
    You, Jinqi
    Tang, Yan
    Zhao, Jingjing
    Weng, Desheng
    BMC CANCER, 2024, 24 (01)
  • [10] PALLIATIVE CARBOPLATIN CHEMOTHERAPY IN PREVIOUSLY TREATED HIGH-GRADE GLIOMA: REAL-WORLD EFFICACY AND SAFETY
    Gupta, Meetakshi
    Mulholland, Paul
    Wilson, Elena
    Fersht, Naomi
    Kosmin, Michael
    NEURO-ONCOLOGY, 2022, 24 : 22 - 22